Dyne therapeutics competitors

Author: oyjp

August undefined, 2024

WebDec 30, 2024 · Peers & Competitors. Follow $11.59 0.19 (+1.67%) 3:59 PM 12/30/22. ... Dyne Therapeutics, Inc. (DYN) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability ... WebDyne Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference WALTHAM, Mass., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. …

Dyne Therapeutics Company Profile: Stock Performance

WebThe Competitors page allows you to view information for other symbols found in the same sector. In the table, you'll find all the components (individual stock symbols) found in that … WebApr 9, 2024 · Dyne Therapeutics, Inc. Competitors. Emergent BioSolutions. NYSE:EBS US$529.5m. 4D Molecular Therapeutics. NasdaqGS:FDMT US$535.7m. Alector. NasdaqGS:ALEC US$518.1m. ARS Pharmaceuticals. NasdaqGM:SPRY US$549.4m. Price History & Performance. ... Dyne Therapeutics, Inc., a muscle disease company, … cure heroin addiction

Dyne Therapeutics LinkedIn

WebFeb 9, 2024 · Competitors: Unknown. Dyne Therapeutics Reviews ... Glassdoor gives you an inside look at what it's like to work at Dyne Therapeutics, including salaries, … WebFind company research, competitor information, contact details & financial data for Dyne Therapeutics, Inc. of Waltham, MA. Get the latest business insights from Dun & … WebFind Dyne Therapeutics stock competitors. Compare other stocks that are similar to DYN in performance, different metrics, and ratios. ... Dyne Therapeutics (DYN) Similar … easy flex golden indian herb

Investors & Media Dyne Therapeutics, Inc.

Dyne Therapeutics Announces Presentations on its DM1 and

WebDyne Therapeutics has 5 employees at their 1 location and $165 m in total funding,. See insights on Dyne Therapeutics including office locations, competitors, revenue, … WebMar 20, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically … cure herbals hair removal reviewsWebMar 30, 2024 · 85.5% of Dyne Therapeutics shares are held by institutional investors. 43.7% of Precigen shares are held by insiders. Comparatively, 42.3% of Dyne … cure high drug prices act

"WebNov 3, 2024 · Cash position: Cash, cash equivalents and marketable securities were $248.1 million as of September 30, 2024, which is anticipated to fund operations through 2024. Research and development (R&D) expenses: R&D expenses were $34.7 million for the quarter ended September 30, 2024, compared to $36.5 million for the quarter ended … " - Dyne therapeutics competitors

Dyne therapeutics competitors

WebFind contact information for Dyne Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Dyne Therapeutics's email format. ... Dyne Therapeutics Top Competitors. Company Employees Revenue Top technologies; Akouos. 57: $19.2 M: Generation Bio. 106: $18.5 M: Leap Therapeutics. …

Did you know?

WebFind contact information for Dyne Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Dyne Therapeutics's … WebSep 6, 2024 · Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to …

WebApr 4, 2024 · 5 brokerages have issued twelve-month target prices for Dyne Therapeutics' shares. Their DYN share price forecasts range from $18.00 to $34.00. On average, they … WebDyne Therapeutics’s Profile, Revenue and Employees. Dyne is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic diseases. Dyne Therapeutics’s primary competitors include Avidity Biosciences, Sarepta Therapeutics, Neurana and 6 more.

WebDyne Therapeutics Inc Working Capital Per Revenue on the trailing twelve month basis from the forth quarter 2024 to forth quarter 2024, Trends and Ranking, Fundamental Ratios - CSIMarket ... Dyne Therapeutics Inc 's Competition Performance; Dyne Therapeutics Inc 's Competitors Results; DYN's Competitors Stock Performance; WebDyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven …

WebApr 3, 2024 · “ Dyne’s breakthrough approach brings the power of modern oligo therapeutics and other payloads to patients with serious muscle diseases," said Jason Rhodes, a partner at Atlas Venture and ...

WebApr 4, 2024 · Dyne Therapeutics currently has a consensus target price of $25.83, suggesting a potential upside of 133.79%. Given Dyne Therapeutics’ higher possible upside, equities analysts plainly believe ... cure herpes with alkaline foodWebFind real-time DYN - Dyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. DYN - Dyne Therapeutics Inc Stock quote - … cure herpes naturally foreverWebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. cure hiatal hernia without surgeryWebDec 30, 2024 · Peers & Competitors. Follow $11.59 0.19 (+1.67%) 3:59 PM 12/30/22. ... Dyne Therapeutics, Inc. (DYN) key stats comparison: compare with other stocks by … easy flex herbWebOct 2, 2024 · Dyne Therapeutics Competitors. There are no companies similar to Dyne Therapeutics Dyne Therapeutics Related Companies. ... No industry vertical has been recorded for Dyne Therapeutics View All. Dyne Therapeutics Recommended Market Profiles (6) Telemedicine. 10,000 or More employees. 19 companies. easyflex aluminum landscape edging 1806WebMay 16, 2024 · About Dyne Therapeutics. Dyne Therapeutics is building a leading muscle disease company dedicated to advancing innovative life-transforming therapeutics for people living with genetically driven diseases. ... Sector and Competitors. 1st jan. Capi. (M$) DYNE THERAPEUTICS, INC.-26.40%: 497: MODERNA, INC.-13.39%: 59 996: … curehiphopWebDyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary ... easy flexibility